Bain Capital Specialty Finance (NYSE:BCSF) reported third-quarter net investment income of $0.43 per share, enough to cover its regular dividend, while executives said they were reviewing the payout as the company faces higher financing costs in 2027.
Net investment income was $27.7 million for the quarter ended September 30, 2026, down from $28.6 million, or $0.44 per share, in the prior quarter. The latest result covered the company’s $0.42-per-share regular dividend by 102%, Chief Executive Officer Michael Ewald said on the earnings call.
Net income was $16.7 million, or $0.26 per share, after $11 million in net realized and unrealized losses. Net asset value per share fell to $16.49 from $16.65 at the end of June.
Dividend Review and Financing Costs
The board declared a fourth-quarter dividend of $0.42 per share for shareholders of record as of December 15, 2026. Ewald said the payout represented an annualized rate of 10.2% on the company’s third-quarter ending book value.
Management is evaluating the dividend with the board as the company’s liability structure resets to higher rates following the maturity of low-cost unsecured notes. Ewald said the goal was a dividend that remains attractive and competitive while being supported by core earnings.
The company estimated spillover income at $1.29 per share, which Ewald said could support the regular dividend and potentially a special dividend near year-end to manage tax requirements. He did not announce a change to the dividend policy.
Chief Financial Officer Amit Joshi said the company’s 2026 notes were repaid when they matured in October. Based on the September 30 balance sheet and accounting for that repayment, management estimated that a 100-basis-point increase in base rates could raise quarterly earnings by approximately $0.01 per share.
Slower Investment Activity, Lower Leverage
Third-quarter investment fundings totaled $121.5 million, including $47.9 million in five new companies and $73.6 million in 115 existing companies, President Mike Boyle said. Sales and repayments of approximately $203 million resulted in net sales and repayments of about $82 million.
Ewald said sponsor-backed merger and acquisition activity remained well below historical levels, while macroeconomic and geopolitical uncertainty kept some buyers and sellers on the sidelines. The company also moderated originations as it worked to bring leverage closer to the middle of its target range.
Of new fundings, 95% went into first-lien structures. Ewald said spreads on new first-lien originations averaged 525 to 600 basis points, excluding one lower-spread investment by the company’s SLP joint venture.
Total debt-to-equity declined to 1.25 times at quarter-end from 1.41 times at the end of June. Net leverage fell to 1.18 times from 1.22 times. Liquidity totaled $962 million, including $887 million of undrawn revolving credit capacity.
Asked about stock buybacks, Ewald said lower leverage could give the company more room to consider them. He said the board weighs potential short-term benefits against the possibility of lower longer-term earnings power and a further reduction in the stock’s available float.
Credit Quality and Joint Ventures
Non-accrual investments represented 2.2% of the portfolio at fair value, unchanged from the prior quarter, and 3.3% at amortized cost. The company added one investment to non-accrual and removed A&R Logistics after a restructuring.
Boyle said the company took control of A&R through the restructuring and that its valuation was consistent with historical marks. He said the business had underperformed since the COVID period.
Investments on the company’s watchlist increased to 7.4% of the portfolio at fair value from 5.8% in the prior quarter. Boyle attributed the increase to softness at a few healthcare companies, primarily because of lower patient acquisition and higher labor costs. He said 94% of watchlist exposures were first-lien senior secured loans.
The SLP joint venture generated a 19% return on equity over the past four quarters, while ISLP returned 9%, modestly below management’s low-double-digit target, Boyle said. He attributed ISLP’s softer result to a couple of credit losses over the past 12 months and leverage below target because its portfolio was more concentrated than desired.
Boyle said asset transfers involving the joint venture were intended to improve diversification. He added that management expected recent moves to help reposition the portfolio toward double-digit returns, though he described high-single-digit to low-double-digit returns as the expected range going forward.
Payment-in-kind interest represented 13% of total investment income in the third quarter. Joshi said 83% of that PIK income came from investments originally underwritten with PIK terms, with the remainder related to amended or restructured investments. He said collections during the quarter were not substantial; Boyle added that the company had no meaningful exits from PIK positions.
About Bain Capital Specialty Finance (NYSE:BCSF)
Bain Capital Specialty Finance, Inc. (NYSE: BCSF) is a business development company that provides financing to middle-market companies. The company primarily invests in privately negotiated debt investments, with an emphasis on senior secured loans, including first-lien and unitranche facilities. It may also invest in second-lien debt and, to a lesser extent, equity securities. BCSF seeks to support companies that are generally sponsored by private equity firms and operates across a range of industries.
